{"id":"https://openalex.org/W2773830451","doi":"https://doi.org/10.15252/emmm.201708076","title":"An oligoclonal antibody durably overcomes resistance of lung cancer to third\u2010generation EGFR inhibitors","display_name":"An oligoclonal antibody durably overcomes resistance of lung cancer to third\u2010generation EGFR inhibitors","alternate_titles":[],"publication_year":2017,"publication_date":"2017-12-06","ids":{"openalex":"https://openalex.org/W2773830451","doi":"https://doi.org/10.15252/emmm.201708076","mag":"2773830451","pmid":"https://pubmed.ncbi.nlm.nih.gov/29212784","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5801506"},"language":"en","primary_location":{"id":"doi:10.15252/emmm.201708076","doi":"https://doi.org/10.15252/emmm.201708076","is_oa":true,"landing_page_url":"https://doi.org/10.15252/emmm.201708076","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/emmm.201708076","source":{"id":"https://openalex.org/S163075119","display_name":"EMBO Molecular Medicine","issn_l":"1757-4676","issn":["1757-4676","1757-4684"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EMBO Molecular Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2773830451"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/emmm.201708076","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066690431","display_name":"Maicol Mancini","orcid":"https://orcid.org/0000-0002-7472-0786","observed_orcids":["https://orcid.org/0000-0002-7472-0786"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maicol Mancini","raw_affiliation_strings":["Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044928987","display_name":"Hilah Gal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hilah Gal","raw_affiliation_strings":["Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045592767","display_name":"Nad\u00e8ge Gaborit","orcid":"https://orcid.org/0000-0001-6447-6735","observed_orcids":["https://orcid.org/0000-0001-6447-6735"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nad\u00e8ge Gaborit","raw_affiliation_strings":["Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060100077","display_name":"Luigi Mazzeo","orcid":"https://orcid.org/0000-0002-8253-6575","observed_orcids":["https://orcid.org/0000-0002-8253-6575"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luigi Mazzeo","raw_affiliation_strings":["Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014810337","display_name":"Donatella Romaniello","orcid":"https://orcid.org/0000-0001-8278-1637","observed_orcids":["https://orcid.org/0000-0001-8278-1637"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Donatella Romaniello","raw_affiliation_strings":["Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110347197","display_name":"Tomer Meir Salame","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tomer Meir Salame","raw_affiliation_strings":["Department of Biological Services, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Services, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011594133","display_name":"Moshit Lindzen","orcid":"https://orcid.org/0000-0002-4485-1355","observed_orcids":["https://orcid.org/0000-0002-4485-1355"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Moshit Lindzen","raw_affiliation_strings":["Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002134047","display_name":"Georg Mahlknecht","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Georg Mahlknecht","raw_affiliation_strings":["Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041459518","display_name":"Yehoshua Enuka","orcid":"https://orcid.org/0000-0001-6327-2845","observed_orcids":["https://orcid.org/0000-0001-6327-2845"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yehoshua Enuka","raw_affiliation_strings":["Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":"https://orcid.org/0000-0001-6327-2845","affiliations":[{"raw_affiliation_string":"Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027190196","display_name":"Dominick G. A. Burton","orcid":"https://orcid.org/0000-0003-3631-6448","observed_orcids":["https://orcid.org/0000-0003-3631-6448"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dominick GA Burton","raw_affiliation_strings":["Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041362750","display_name":"L. E. Roth","orcid":"https://orcid.org/0000-0001-9290-2463","observed_orcids":["https://orcid.org/0000-0001-9290-2463"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lee Roth","raw_affiliation_strings":["Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034212588","display_name":"Ashish Noronha","orcid":"https://orcid.org/0000-0002-3415-6113","observed_orcids":["https://orcid.org/0000-0002-3415-6113"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ashish Noronha","raw_affiliation_strings":["Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022522838","display_name":"Ilaria Marrocco","orcid":"https://orcid.org/0000-0002-8225-2177","observed_orcids":["https://orcid.org/0000-0002-8225-2177"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ilaria Marrocco","raw_affiliation_strings":["Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048795422","display_name":"Dan Adreka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dan Adreka","raw_affiliation_strings":["Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059396772","display_name":"Raya Eilam\u2010Altstadter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Raya Eilam Altstadter","raw_affiliation_strings":["Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113492527","display_name":"Emilie Bousquet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Emilie Bousquet","raw_affiliation_strings":["Oncogenic Pathways in Lung Cancer, Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Inserm U1194, Montpellier Cedex 5, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncogenic Pathways in Lung Cancer, Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Inserm U1194, Montpellier Cedex 5, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210140335"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011616773","display_name":"Julian Downward","orcid":"https://orcid.org/0000-0002-2331-4729","observed_orcids":["https://orcid.org/0000-0002-2331-4729"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2801081054","display_name":"The Francis Crick Institute","ror":"https://ror.org/04tnbqb63","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801081054"]},{"id":"https://openalex.org/I4405285715","display_name":"National Institute for Medical Research","ror":"https://ror.org/00146rb91","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801081054","https://openalex.org/I4210087105","https://openalex.org/I4405285715","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Julian Downward","raw_affiliation_strings":["Lung Cancer Group, The Institute of Cancer Research, London, UK","Signal Transduction Laboratory, Francis Crick Institute, London, UK","The Francis Crick Institute [London] (Mill Hill Laboratory, London - Royaume-Uni)","The institute of cancer research [London] (123 Old Brompton Road\r\nLondon SW7 3RP - Royaume-Uni)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lung Cancer Group, The Institute of Cancer Research, London, UK","institution_ids":["https://openalex.org/I142947616"]},{"raw_affiliation_string":"Signal Transduction Laboratory, Francis Crick Institute, London, UK","institution_ids":["https://openalex.org/I2801081054"]},{"raw_affiliation_string":"The Francis Crick Institute [London] (Mill Hill Laboratory, London - Royaume-Uni)","institution_ids":["https://openalex.org/I4405285715"]},{"raw_affiliation_string":"The institute of cancer research [London] (123 Old Brompton Road\r\nLondon SW7 3RP - Royaume-Uni)","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061151865","display_name":"Antonio Maraver","orcid":"https://orcid.org/0000-0002-5527-5680","observed_orcids":["https://orcid.org/0000-0002-5527-5680"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Antonio Maraver","raw_affiliation_strings":["Oncogenic Pathways in Lung Cancer, Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Inserm U1194, Montpellier Cedex 5, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncogenic Pathways in Lung Cancer, Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), Inserm U1194, Montpellier Cedex 5, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210140335"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091821891","display_name":"Valery Krizhanovsky","orcid":"https://orcid.org/0000-0002-3977-5482","observed_orcids":["https://orcid.org/0000-0002-3977-5482"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Valery Krizhanovsky","raw_affiliation_strings":["Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":"https://orcid.org/0000-0002-3977-5482","affiliations":[{"raw_affiliation_string":"Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001348816","display_name":"Yosef Yarden","orcid":"https://orcid.org/0000-0001-8578-0250","observed_orcids":["https://orcid.org/0000-0001-8578-0250"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Yosef Yarden","raw_affiliation_strings":["Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel yosef.yarden@weizmann.ac.il","Department of Biological Regulation Weizmann Institute of Science Rehovot Israel"],"raw_orcid":"https://orcid.org/0000-0001-8578-0250","affiliations":[{"raw_affiliation_string":"Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel yosef.yarden@weizmann.ac.il","institution_ids":["https://openalex.org/I53964585"]},{"raw_affiliation_string":"Department of Biological Regulation Weizmann Institute of Science Rehovot Israel","institution_ids":["https://openalex.org/I53964585"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5001348816"],"corresponding_institution_ids":["https://openalex.org/I53964585"],"apc_list":{"value":7990,"currency":"USD","value_usd":7990},"apc_paid":{"value":7990,"currency":"USD","value_usd":7990},"fwci":3.2044,"has_fulltext":true,"cited_by_count":54,"citation_normalized_percentile":{"value":0.92127233,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"10","issue":"2","first_page":"294","last_page":"308"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.8199999928474426},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.734000027179718},{"id":"https://openalex.org/keywords/egfr-c797s-mutation","display_name":"C797S mutation","score":0.9459999799728394},{"id":"https://openalex.org/keywords/egfr-t790m-mutation","display_name":"T790M mutation","score":0.9570000171661377},{"id":"https://openalex.org/keywords/oligoclonal-antibodies","display_name":"oligoclonal antibodies","score":0.8500000238418579},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.8659999966621399},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":1.0},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.6779999732971191},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.9990000128746033},{"id":"https://openalex.org/keywords/osimertinib","display_name":"osimertinib","score":0.9629999995231628},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.734000027179718},{"id":"https://openalex.org/keywords/cellular-senescence","display_name":"cellular senescence","score":0.9750000238418579},{"id":"https://openalex.org/keywords/receptor-degradation","display_name":"receptor degradation","score":0.8830000162124634}],"concepts":[{"id":"https://openalex.org/C161191863","wikidata":"https://www.wikidata.org/wiki/Q199655","display_name":"Library science","level":1,"score":0.48099812865257263},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.21805104613304138}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000178","descriptor_name":"Acrylamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000814","descriptor_name":"Aniline Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":8,"locations":[{"id":"doi:10.15252/emmm.201708076","doi":"https://doi.org/10.15252/emmm.201708076","is_oa":true,"landing_page_url":"https://doi.org/10.15252/emmm.201708076","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/emmm.201708076","source":{"id":"https://openalex.org/S163075119","display_name":"EMBO Molecular Medicine","issn_l":"1757-4676","issn":["1757-4676","1757-4684"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EMBO Molecular Medicine","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4722216","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5801506","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5801506","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5801506/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EMBO Mol Med","raw_type":"Text"},{"id":"pmid:29212784","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29212784","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EMBO molecular medicine","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-02283055v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.umontpellier.fr/hal-02283055v1/document","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"EMBO Molecular Medicine, 2018, 10 (2), pp.294-308. &#x27E8;10.15252/emmm.201708076&#x27E9;","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:cris.unibo.it:11585/868318","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/11585/868318","pdf_url":null,"source":{"id":"https://openalex.org/S4306402579","display_name":"Archivio istituzionale della ricerca (Alma Mater Studiorum Universit\u00e0 di Bologna)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210117483","host_organization_name":"Istituto di Ematologia di Bologna","host_organization_lineage":["https://openalex.org/I4210117483"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:29209c6b4c714c0b85c5ff5816ce736b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/29209c6b4c714c0b85c5ff5816ce736b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"EMBO Molecular Medicine, Vol 10, Iss 2, Pp 294-308 (2017)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/12860048","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/An_oligoclonal_antibody_durably_overcomes_resistance_of_lung_cancer_to_third-generation_EGFR_inhibitors/12860048","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.15252/emmm.201708076","doi":"https://doi.org/10.15252/emmm.201708076","is_oa":true,"landing_page_url":"https://doi.org/10.15252/emmm.201708076","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/emmm.201708076","source":{"id":"https://openalex.org/S163075119","display_name":"EMBO Molecular Medicine","issn_l":"1757-4676","issn":["1757-4676","1757-4684"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EMBO Molecular Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5303268458","display_name":null,"funder_award_id":"10070","funder_id":"https://openalex.org/F4320312060","funder_display_name":"Francis Crick Institute"},{"id":"https://openalex.org/G8591520557","display_name":null,"funder_award_id":"15680","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"}],"funders":[{"id":"https://openalex.org/F4320312060","display_name":"Francis Crick Institute","ror":"https://ror.org/04tnbqb63"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2773830451.pdf","grobid_xml":"https://content.openalex.org/works/W2773830451.grobid-xml"},"referenced_works_count":53,"referenced_works":["https://openalex.org/W34001300","https://openalex.org/W127707871","https://openalex.org/W1546552389","https://openalex.org/W1904060183","https://openalex.org/W1948348021","https://openalex.org/W1972117739","https://openalex.org/W1973300568","https://openalex.org/W1982481909","https://openalex.org/W1986525211","https://openalex.org/W1990013637","https://openalex.org/W2002937040","https://openalex.org/W2003984225","https://openalex.org/W2004273407","https://openalex.org/W2019276374","https://openalex.org/W2038454445","https://openalex.org/W2043668664","https://openalex.org/W2043696829","https://openalex.org/W2047119143","https://openalex.org/W2050211354","https://openalex.org/W2055346925","https://openalex.org/W2065141010","https://openalex.org/W2072084159","https://openalex.org/W2076178766","https://openalex.org/W2091083398","https://openalex.org/W2095618958","https://openalex.org/W2100626226","https://openalex.org/W2104397341","https://openalex.org/W2114095518","https://openalex.org/W2117784514","https://openalex.org/W2122080125","https://openalex.org/W2122618533","https://openalex.org/W2126177831","https://openalex.org/W2128402413","https://openalex.org/W2129656399","https://openalex.org/W2130930654","https://openalex.org/W2133963438","https://openalex.org/W2139236349","https://openalex.org/W2140755317","https://openalex.org/W2153636914","https://openalex.org/W2159680772","https://openalex.org/W2161821474","https://openalex.org/W2164613605","https://openalex.org/W2165259537","https://openalex.org/W2166084034","https://openalex.org/W2174769990","https://openalex.org/W2256505400","https://openalex.org/W2272802268","https://openalex.org/W2275679174","https://openalex.org/W2325071936","https://openalex.org/W2468644245","https://openalex.org/W2560717039","https://openalex.org/W2591118779","https://openalex.org/W4235389138"],"related_works":["https://openalex.org/W7006233890","https://openalex.org/W3049768565","https://openalex.org/W2588524909","https://openalex.org/W2618442076","https://openalex.org/W3170835126","https://openalex.org/W2912617737","https://openalex.org/W2569357796","https://openalex.org/W2953666924","https://openalex.org/W2809998238","https://openalex.org/W2809980410"],"abstract_inverted_index":{")":[0],"mutations":[1],"identify":[2],"patients":[3,15],"with":[4,95,119],"lung":[5],"cancer":[6],"who":[7],"derive":[8],"benefit":[9],"from":[10],"kinase":[11,120],"inhibitors.":[12],"However,":[13],"most":[14],"eventually":[16],"develop":[17],"resistance,":[18],"primarily":[19],"due":[20],"to":[21],"the":[22,87],"T790M":[23],"second-site":[24],"mutation.":[25],"Irreversible":[26],"inhibitors":[27],"(e.g.,":[28],"osimertinib/AZD9291)":[29],"inhibit":[30],"T790M-EGFR,":[31],"but":[32],"several":[33],"mechanisms,":[34,97],"including":[35,68],"a":[36,47,69],"third-site":[37],"mutation,":[38],"C797S,":[39],"confer":[40],"renewed":[41],"resistance.":[42,132],"We":[43,63],"previously":[44],"reported":[45],"that":[46,66],"triple":[48],"mixture":[49],"of":[50,86,104,126,131],"monoclonal":[51],"antibodies,":[52,113],"3\u00d7mAbs,":[53,67],"simultaneously":[54],"targeting":[55],"EGFR,":[56],"HER2,":[57],"and":[58,73,90,107,128],"HER3,":[59],"inhibits":[60,75],"T790M-expressing":[61],"tumors.":[62,77,110],"now":[64],"report":[65],"triplet":[70],"containing":[71],"cetuximab":[72],"trastuzumab,":[74],"C797S-expressing":[76],"Unlike":[78],"osimertinib,":[79],"which":[80],"induces":[81,91],"apoptosis,":[82],"3\u00d7mAbs":[83,100],"promotes":[84],"degradation":[85],"three":[88],"receptors":[89],"cellular":[92],"senescence.":[93],"Consistent":[94],"distinct":[96],"treatments":[98],"combining":[99],"plus":[101],"sub-inhibitory":[102],"doses":[103],"osimertinib":[105],"synergistically":[106],"persistently":[108],"eliminated":[109],"Thus,":[111],"oligoclonal":[112],"either":[114],"alone":[115],"or":[116],"in":[117],"combination":[118],"inhibitors,":[121],"might":[122],"preempt":[123],"repeated":[124],"cycles":[125],"treatment":[127],"rapid":[129],"emergence":[130]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2773830451","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-12-22T00:00:00"}
